Back

Machine Learning with Objective Serum Markers and Algorithmic Deep Learning Computed Tomography Scan Analysis for Classification of Brain Injury

Rafter, D.; Li, Z.; Schaaf, T.; Gault, K.; Thorpe, M.; Edpuganti, R.; Song, T.; Kuang, R.; Samadani, U.

2021-06-16 neurology
10.1101/2021.02.13.21250776 medRxiv
Show abstract

BackgroundBrain injury is pathophysiologically diverse, with many cases presenting with mixed pathologies. Utilizing objective measures to investigate the pathophysiology of injury would aid in understanding prognosis and targeting therapeutics. ObjectiveThe goal of this study is to develop a traumatic brain injury classification scheme based on open source deep learning computer tomography (CT) analysis and the two serum biomarkers, glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal L1 (UCH-L1). MethodsMachine learning was utilized to develop a novel algorithm capable of classifying the type of brain injury based on a CT scan analysis algorithm and GFAP and UCH-L1 concentrations. Injury was stratified into one of four groups: spontaneous hemorrhage, oxygen deprivation, trauma resulting in vascular injury or high-velocity trauma with negative CT scan. Outcomes100 research subjects were enrolled. Using a combination of CT analysis and serum markers, the subjects with CT positive trauma were distinguishable from those with spontaneous hemorrhage, ischemic injury, CT negative trauma and controls with AUCs of 0.96, 0.99., 0.98 and 1.00 respectively. Ischemic injury was distinguishable from CT positive trauma with an AUC of 0.98. All forms of brain injury could be distinguished from controls with AUC = 1.00. DiscussionAn open source algorithmic CT scan analysis algorithm and serum biomarkers accurately classified the nature of brain injury across major etiologies. Further implementation of such algorithms and addition of other objective measures will enable better prognostication of injury and improved development of therapeutics.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Neurocritical Care
11 papers in training set
Top 0.1%
10.5%
2
Frontiers in Neurology
91 papers in training set
Top 0.5%
10.1%
3
Journal of Neurotrauma
27 papers in training set
Top 0.1%
8.4%
4
Brain Communications
147 papers in training set
Top 0.5%
4.4%
5
BMC Neurology
12 papers in training set
Top 0.1%
4.3%
6
Journal of Neurology
26 papers in training set
Top 0.2%
4.0%
7
PLOS ONE
4510 papers in training set
Top 35%
4.0%
8
Scientific Reports
3102 papers in training set
Top 36%
3.6%
9
Journal of Neurology, Neurosurgery & Psychiatry
29 papers in training set
Top 0.4%
2.6%
50% of probability mass above
10
Journal of the Neurological Sciences
17 papers in training set
Top 0.1%
2.4%
11
Brain and Behavior
37 papers in training set
Top 0.3%
2.1%
12
Neurology
44 papers in training set
Top 0.7%
1.9%
13
Annals of Neurology
57 papers in training set
Top 1.0%
1.9%
14
Stroke
35 papers in training set
Top 0.5%
1.9%
15
Neuroinformatics
40 papers in training set
Top 0.5%
1.7%
16
EClinicalMedicine
21 papers in training set
Top 0.3%
1.7%
17
Annals of Clinical and Translational Neurology
29 papers in training set
Top 0.6%
1.5%
18
Frontiers in Integrative Neuroscience
12 papers in training set
Top 0.1%
1.3%
19
BMJ Open
554 papers in training set
Top 11%
1.2%
20
Journal of the American Heart Association
119 papers in training set
Top 3%
1.2%
21
Journal of Clinical Medicine
91 papers in training set
Top 4%
1.2%
22
Journal of Stroke and Cerebrovascular Diseases
12 papers in training set
Top 0.4%
1.2%
23
NeuroImage: Clinical
132 papers in training set
Top 3%
1.0%
24
Biomedicines
66 papers in training set
Top 2%
1.0%
25
Biological Psychiatry Global Open Science
54 papers in training set
Top 1%
0.8%
26
Brain Sciences
52 papers in training set
Top 2%
0.8%
27
iScience
1063 papers in training set
Top 29%
0.8%
28
Informatics in Medicine Unlocked
21 papers in training set
Top 1%
0.8%
29
Diagnostics
48 papers in training set
Top 2%
0.7%
30
Neuro-Oncology Advances
24 papers in training set
Top 0.5%
0.7%